Hubei Xunda Pharmaceutical
Latest round
- Series A
Last raised
- Jun 2008
Total raised
- $1.8M
Investors
- 1
About Hubei Xunda Pharmaceutical
Hubei Xunda Pharmaceutical operates as a producer of anti-inflammation and pain easing drugs in China. The firm's main product is ketoprofen.
Who invested in Hubei Xunda Pharmaceutical
1 investor across 1 round
See all investors in Hubei Xunda Pharmaceutical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 1, 2008
Amount
$1.8M
Investors
Questions about Hubei Xunda Pharmaceutical
Who invested in Hubei Xunda Pharmaceutical?
Hubei Xunda Pharmaceutical has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hubei Xunda Pharmaceutical raised?
Hubei Xunda Pharmaceutical has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Hubei Xunda Pharmaceutical last raise money?
Hubei Xunda Pharmaceutical's most recent round on record is a Series A, in Jun 2008.
What does Hubei Xunda Pharmaceutical do?
Hubei Xunda Pharmaceutical operates as a producer of anti-inflammation and pain easing drugs in China.
Where is Hubei Xunda Pharmaceutical headquartered?
Hubei Xunda Pharmaceutical is headquartered in Wuxue, China.
Which VCs invest in companies like Hubei Xunda Pharmaceutical?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Hubei Xunda Pharmaceutical's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Hubei Xunda Pharmaceutical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.